The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms
Open Access
- 1 May 2019
- journal article
- research article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 15, 1181-1191
Abstract
Objective: It is common that major depressive disorder (MDD) is accompanied by gastrointestinal (GI) symptoms. However, few studies have focused on the clinical characteristics and its possible mechanism, while brain gray matter (GM) structure is important in the pathogenesis of GI symptoms. In this study, we aimed to investigate the basic clinical characteristics and regional GM volume changes in MDD accompanied by GI symptoms. Method: Patients with MDD (n=49) and age, gender, and educational level-matched healthy controls (n=30) were recruited. Patients with MDD were divided into two groups based on the GI status: MDD with (n=27) and without (n=22) GI symptoms. The 24-item Hamilton Depression Rating Scale (HAMD) was administered. T1-weighted anatomical images were obtained and analyzed. Correlation analysis was used to identify the possible associations between changed regional GM volume and GI symptoms and depressive symptoms. Results: The HAMD reductive ratio for 2 weeks of treatment in the GI symptoms group was significantly higher than the non-GI symptoms group (PPP P P Conclusion: The changed regional brain GM volume in GI-MDD group may be the pathogenesis for the GI symptoms. In addition, the GI symptoms may predict the prognosis of MDD.Keywords
This publication has 40 references indexed in Scilit:
- Are Somatic Symptoms of Depression Better Predictors of Cardiac Events Than Cognitive Symptoms in Coronary Heart Disease?Psychosomatic Medicine, 2012
- Abnormal Resting Brain Activity in Patients With Functional Dyspepsia Is Related to Symptom SeverityGastroenterology, 2011
- Can Neuroimaging Help Us to Understand and Classify Somatoform Disorders? A Systematic and Critical ReviewPsychosomatic Medicine, 2011
- Regional Gray Matter Density Changes in Brains of Patients With Irritable Bowel SyndromeGastroenterology, 2010
- Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: A 3T-fMRI studyPain, 2010
- Cortical deactivations during gastric fundus distension in health: visceral pain‐specific response or attenuation of ‘default mode’ brain function? A H215O‐PET studyNeurogastroenterology & Motility, 2009
- Relationship of Somatic Symptoms With Depression Severity, Quality of Life, and Health Resources Utilization in Patients With Major Depressive Disorder Seeking Primary Health Care in SpainThe Primary Care Companion For CNS Disorders, 2008
- The 5-HT 3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised ratGut, 2000
- An International Study of the Relation between Somatic Symptoms and DepressionNew England Journal of Medicine, 1999
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960